Matrix Metalloproteinase-9 in Cerebral Aneurysms
- 1 September 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 41 (3) , 642-647
- https://doi.org/10.1097/00006123-199709000-00027
Abstract
OBJECTIVE:. Generalized disruption of arterial wall morphological changes in patients harboring cerebral aneurysms has been documented; however, littleKeywords
This publication has 19 references indexed in Scilit:
- Prevalence of Risk Factors in Spontaneous Intracerebral Hemorrhage and Aneurysmal Subarachnoid HemorrhageArchives of Neurology, 1996
- Plasminogen activator and plasminogen activator inhibitor expression by normal and aneurysmal human aortic smooth muscle cells in cultureEuropean Journal of Vascular and Endovascular Surgery, 1995
- Inflammation and Matrix Metalloproteinases in the Enlarging Abdominal Aortic AneurysmArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Serum metalloproteinases and their inhibitors: markers for malignant potentialBritish Journal of Cancer, 1994
- Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cellsBiochemical Journal, 1992
- Decreased tissue inhibitor of metalloproteinases (TIMP) in abdominal aortic aneurysm tissue: A preliminary reportJournal of Surgical Research, 1991
- The Peripheral Vascular Consequences of SmokingAnnals of Vascular Surgery, 1991
- Metalloproteinases and their inhibitors in matrix remodelingTrends in Genetics, 1990
- Systemic administration of TIMP in the treatment of collagen-induced arthritis in miceInflammation Research, 1989
- Degradation of glomerular basement membrane by purified mammalian metalloproteinasesBiochemical Journal, 1988